Kodiak Sciences Inc.(KOD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

KOD Kodiak Sciences Inc.

Market Closed 12-12 16:00:00 EST

23.81

-0.32

-1.33%

盘后23.81

+0.000.00%

18:15 EST

High24.95	Low23.62	Vol423.35K
Open24.70	D1 Closing24.13	Amplitude5.51%
Mkt Cap1.26B	Tradable Cap771.87M	Total Shares53.05M
T/O10.19M	T/O Rate1.31%	Tradable Shares32.42M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"KOD","market":"US","secType":"STK","nameCN":"Kodiak Sciences Inc.","latestPrice":23.81,"timestamp":1765573200000,"preClose":24.13,"halted":0,"volume":423351,"hourTrading":{"tag":"盘后","latestPrice":23.81,"preClose":23.81,"latestTime":"18:15 EST","volume":7950,"amount":189294.9,"timestamp":1765581347251},"delay":0,"floatShares":32418005,"shares":53048428,"eps":-4.119388,"marketStatus":"Market Closed","change":-0.32,"latestTime":"12-12 16:00:00 EST","open":24.7,"high":24.95,"low":23.62,"amount":10192569.04143,"amplitude":0.055118,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.119388,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":24.13,"preHourTrading":{"tag":"盘前","latestPrice":24.6,"preClose":24.13,"latestTime":"09:25 EST","volume":3035,"amount":73909.15159000001,"timestamp":1765549522387},"postHourTrading":{"tag":"盘后","latestPrice":23.81,"preClose":23.81,"latestTime":"18:15 EST","volume":7950,"amount":189294.9,"timestamp":1765581347251},"volumeRatio":0.6896243345393462,"impliedVol":0.7947,"impliedVolPercentile":0.316},"requestUrl":"/m/hq/s/KOD/wiki","defaultTab":"wiki","newsList":[{"id":"2584974193","title":"Kodiak Sciences (KOD): Assessing Valuation Following Q3 Losses and Advancing Pipeline Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2584974193","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584974193?lang=en_us&edition=fundamental","pubTime":"2025-11-20 04:13","pubTimestamp":1763583232,"startTime":"0","endTime":"0","summary":"Kodiak Sciences (KOD) shares were in focus this week after the company reported a larger third quarter net loss. This reflects rising research and development and manufacturing expenses tied to its advancing clinical pipeline.\nSee our latest analysis for Kodiak Sciences.\nDespite Kodiak Sciences’ wider net loss making headlines, investors have shrugged off short-term volatility, with the 1-month share price return climbing 8.6% and the year-to-date gain reaching a remarkable 123%. Even more...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kod/kodiak-sciences/news/kodiak-sciences-kod-assessing-valuation-following-q3-losses","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kod/kodiak-sciences/news/kodiak-sciences-kod-assessing-valuation-following-q3-losses","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["KOD","BK4505","BK4139"],"gpt_icon":0},{"id":"1131928204","title":"Stock Track | Kodiak Sciences Soars 5.02% as H.C. Wainwright Raises Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1131928204","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131928204?lang=en_us&edition=fundamental","pubTime":"2025-11-17 23:08","pubTimestamp":1763392110,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences Inc. (KOD) are soaring 5.02% in pre-market trading on Monday, following a series of analyst actions, most notably a price target increase from H.C. Wainwright. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KOD"],"gpt_icon":0},{"id":"1142190917","title":"Stock Track | Kodiak Sciences Soars 5.02% as H.C. Wainwright Raises Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1142190917","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142190917?lang=en_us&edition=fundamental","pubTime":"2025-11-17 23:08","pubTimestamp":1763392106,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences Inc. (KOD) surged 5.02% in Monday's pre-market trading session following a notable price target upgrade from a prominent Wall Street analyst. The biotechnology company,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KOD"],"gpt_icon":0},{"id":"1157657438","title":"Stock Track | Kodiak Sciences (KOD) Plummets 5.43% in Pre-Market Despite Mixed Analyst Actions","url":"https://stock-news.laohu8.com/highlight/detail?id=1157657438","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157657438?lang=en_us&edition=fundamental","pubTime":"2025-11-17 22:34","pubTimestamp":1763390097,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences Inc. (KOD) plummeted 5.43% in pre-market trading on Monday, despite receiving mixed analyst actions. The significant drop suggests that investors may be responding...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KOD"],"gpt_icon":0},{"id":"1161503302","title":"Stock Track | Kodiak Sciences Plummets 5.43% Despite Analyst Price Target Hike and Neutral Ratings","url":"https://stock-news.laohu8.com/highlight/detail?id=1161503302","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161503302?lang=en_us&edition=fundamental","pubTime":"2025-11-17 22:34","pubTimestamp":1763390092,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc. (KOD) experienced a sharp decline in the pre-market session on Monday, with its stock plummeting 5.43% despite receiving mixed signals from Wall Street analysts. The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KOD"],"gpt_icon":0},{"id":"2584628859","title":"Kodiak Sciences Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2584628859","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584628859?lang=en_us&edition=fundamental","pubTime":"2025-11-17 20:03","pubTimestamp":1763380980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KOD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 17, 2025 07:03 ET (12:03 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","KOD","BK4139"],"gpt_icon":0},{"id":"2584421586","title":"Kodiak Sciences Inc. : H.c. Wainwright Raises Target Price to $26 From $24","url":"https://stock-news.laohu8.com/highlight/detail?id=2584421586","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584421586?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:08","pubTimestamp":1763377737,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nAZN4QTUN6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KOD","BK4505"],"gpt_icon":0},{"id":"2584649450","title":"Barclays Sticks to Its Hold Rating for Kodiak Sciences (KOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584649450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584649450?lang=en_us&edition=fundamental","pubTime":"2025-11-17 17:46","pubTimestamp":1763372817,"startTime":"0","endTime":"0","summary":"Barclays analyst Gena Wang maintained a Hold rating on Kodiak Sciences today and set a price target of $17.00. Wang covers the Healthcare sector, f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-hold-rating-for-kodiak-sciences-kod-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-hold-rating-for-kodiak-sciences-kod-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KOD"],"gpt_icon":0},{"id":"1146345137","title":"Stock Track | Kodiak Sciences Soars 5.09% as Jefferies Raises Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1146345137","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146345137?lang=en_us&edition=fundamental","pubTime":"2025-11-14 22:50","pubTimestamp":1763131842,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences Inc. (KOD) are soaring 5.09% in Friday's pre-market trading session following a positive analyst update. The biotechnology company, which focuses on novel therapies for...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["KOD"],"gpt_icon":0},{"id":"2583714015","title":"U.S. RESEARCH ROUNDUP-Disney, Enanta Pharmaceuticals, Phillips 66","url":"https://stock-news.laohu8.com/highlight/detail?id=2583714015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583714015?lang=en_us&edition=fundamental","pubTime":"2025-11-14 17:48","pubTimestamp":1763113706,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Disney, Enanta Pharmaceuticals, Phillips 66Nov 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nL4N3WQ0PY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOD","STUB","DIS","DRIO","DINO","DK","LU0476273544.USD","SR","ENTA","FLY","BK4084","PARR","SG9999011175.SGD","LU2272731865.HKD","APH","EWTX","SOC","AMGN","ANF","CCAP","ENSG","AMAT","EPC","PLNT","KURA","PSX","BK4505","IE0004445015.USD","INO","WY","MRSN","VLO","LU1153585028.USD","MPC","DYN","CRS","GAP","LU0122379950.USD","PBF","SBH","SG9999014880.SGD","IE00BGHQF417.EUR","LU1035775433.USD","PGR","TDG","ARDT","IE00B5TLWC47.USD","LU0963586101.USD","ACHC"],"gpt_icon":1},{"id":"2583159512","title":"Kodiak Sciences Q3 EPS $(1.16) Misses $(1.03) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2583159512","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583159512?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:29","pubTimestamp":1763069375,"startTime":"0","endTime":"0","summary":"Kodiak Sciences (NASDAQ:KOD) reported quarterly losses of $(1.16) per share which missed the analyst consensus estimate of $(1.03) by 12.51 percent. This is a 38.1 percent decrease over losses of $(0.84) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48851245/kodiak-sciences-q3-eps-1-16-misses-1-03-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NQmain","TQQQ","USAW.SI","NVIW.SI","QID","KOD","USJW.SI","QLD","BK4505","MNQmain","TSYW.SI","BK4139","SQQQ","PSQ",".IXIC"],"gpt_icon":0},{"id":"2583512382","title":"Kodiak Sciences reports Q3 EPS ($1.16), consensus ($1.04)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583512382","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583512382?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:17","pubTimestamp":1763068639,"startTime":"0","endTime":"0","summary":"“Kodiak Sciences (KOD) has entered a period of strong, sustained momentum driven by compelling clinical data, accelerated execution and growing ext...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/kodiak-sciences-reports-q3-eps-1-16-consensus-1-04-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/kodiak-sciences-reports-q3-eps-1-16-consensus-1-04-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KOD","BK4139","BK4505"],"gpt_icon":0},{"id":"2583143195","title":"Kodiak Sciences reports Q3 net loss of $61.5 million on $72 million cash balance","url":"https://stock-news.laohu8.com/highlight/detail?id=2583143195","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583143195?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:07","pubTimestamp":1763068055,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc. reported a net loss of $61.5 million, or $1.16 per share, for the third quarter of 2025, compared to a net loss of $43.9 million, or $0.84 per share, in the same quarter of 2024. Cash and cash equivalents at the end of the third quarter of 2025 were $72.0 million. The net loss for the third quarter of 2025 included a non-cash stock-based compensation expense of $14.0 million, compared to $14.8 million in the third quarter of 2024. During the period, Kodiak announced follow-up data from the Phase 1b APEX study of KSI-101 in macular edema secondary to inflammation, with more than half of patients achieving a vision improvement of three lines or more. The company is advancing Phase 3 programs for tarcocimab and KSI-501 in wet AMD and diabetic retinopathy, with key data readouts expected in 2026 and 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL4Gjryg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","KOD"],"gpt_icon":0},{"id":"2583110235","title":"BRIEF-Kodiak Sciences Q3 Net Income USD -61.457 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583110235","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583110235?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067947,"startTime":"0","endTime":"0","summary":"BRIEF-Kodiak Sciences Q3 Net Income USD -61.457 Million\n\n\nNov 13 (Reuters) - Kodiak Sciences Q3 basic EPS USD -1.16.\n\nQ3 operating income USD -62.352 million\nQ3 operating expenses USD 62.352 million\nQ3 EPS USD -1.16","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLXE250C1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","KOD"],"gpt_icon":0},{"id":"2583714511","title":"Kodiak Sciences Q3 EPS USD -1.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2583714511","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583714511?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:05","pubTimestamp":1763067902,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nPLXE250C1:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","KOD","BK4139"],"gpt_icon":0},{"id":"2583655511","title":"Kodiak Sciences (KOD) Is Up 13.6% After Strong Phase 3 Results for KSI-101 in Uveitic Macular Edema","url":"https://stock-news.laohu8.com/highlight/detail?id=2583655511","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583655511?lang=en_us&edition=fundamental","pubTime":"2025-11-14 02:34","pubTimestamp":1763058851,"startTime":"0","endTime":"0","summary":"Kodiak Sciences announced new Phase 3 clinical trial data at the American Academy of Ophthalmology meetings showing that intraocular interleukin-6 inhibition with KSI-101 led to meaningful improvements in vision and anatomy for patients with uveitic macular edema, and was well tolerated across all dose levels.\nAn especially rapid onset of action, with most of the drying effect seen by Week 1, sets KSI-101 apart in retinal disease treatment research.\nWe’ll examine how positive late-stage...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kod/kodiak-sciences/news/kodiak-sciences-kod-is-up-136-after-strong-phase-3-results-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-kod/kodiak-sciences/news/kodiak-sciences-kod-is-up-136-after-strong-phase-3-results-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["KOD","KSI","BK4505","BK4139"],"gpt_icon":0},{"id":"2583358159","title":"Kodiak Sciences CEO to Present at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2583358159","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583358159?lang=en_us&edition=fundamental","pubTime":"2025-11-13 06:48","pubTimestamp":1762987729,"startTime":"0","endTime":"0","summary":"Kodiak Sciences Inc., a precommercial retina-focused biotechnology company, will participate in the Jefferies Global Healthcare Conference in London, UK, on November 17, 2025. CEO Victor Perlroth will deliver a presentation at 4:30pm GMT.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kodiak Sciences Inc. published the original content used to generate this news brief via PR Newswire  on November 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL1lCvQx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KOD","BK4505"],"gpt_icon":0},{"id":"2582394651","title":"Kodiak Sciences Shares Rise After HC Wainwright Upgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2582394651","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582394651?lang=en_us&edition=fundamental","pubTime":"2025-11-12 03:38","pubTimestamp":1762889889,"startTime":"0","endTime":"0","summary":"Kodiak Sciences  shares rose over 7% in recent Tuesday trading after HC Wainwright upgraded the stock to buy from neutral with a price target of $24 per share.Trading volume stood at more than 477,300 shares compared with a daily average of 892,617.Price: 19.82, Change: +1.33, Percent Change: +7.17","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4505","KOD"],"gpt_icon":0},{"id":"2582616369","title":"Kodiak Sciences Raised to Buy From Neutral by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2582616369","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582616369?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:47","pubTimestamp":1762865220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KOD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 11, 2025 07:47 ET (12:47 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","KOD","BK4139"],"gpt_icon":0},{"id":"2582136527","title":"HC Wainwright Upgrades Kodiak Sciences to Buy From Neutral, Price Target is $24","url":"https://stock-news.laohu8.com/highlight/detail?id=2582136527","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582136527?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:05","pubTimestamp":1762862754,"startTime":"0","endTime":"0","summary":"Kodiak Sciences (KOD) has an average rating of overweight and mean price target of $20.43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4505","KOD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kodiak.com","stockEarnings":[{"period":"1week","weight":-0.0218},{"period":"1month","weight":0.1758},{"period":"3month","weight":1.5741},{"period":"6month","weight":5.1366},{"period":"1year","weight":1.8447},{"period":"ytd","weight":1.393}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.06094},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.132442},{"month":3,"riseRate":0,"avgChangeRate":-0.148215},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.000503},{"month":5,"riseRate":0.571429,"avgChangeRate":0.076422},{"month":6,"riseRate":0.714286,"avgChangeRate":0.026986},{"month":7,"riseRate":0.571429,"avgChangeRate":0.078061},{"month":8,"riseRate":0.571429,"avgChangeRate":0.018756},{"month":9,"riseRate":0.714286,"avgChangeRate":0.127765},{"month":10,"riseRate":0.714286,"avgChangeRate":0.212883},{"month":11,"riseRate":0.75,"avgChangeRate":0.296496},{"month":12,"riseRate":0.625,"avgChangeRate":0.243828}],"exchange":"NASDAQ","name":"Kodiak Sciences Inc.","nameEN":"Kodiak Sciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Kodiak Sciences Inc.(KOD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Kodiak Sciences Inc.(KOD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Kodiak Sciences Inc.,KOD,Kodiak Sciences Inc.股票,Kodiak Sciences Inc.股票老虎,Kodiak Sciences Inc.股票老虎国际,Kodiak Sciences Inc.行情,Kodiak Sciences Inc.股票行情,Kodiak Sciences Inc.股价,Kodiak Sciences Inc.股市,Kodiak Sciences Inc.股票价格,Kodiak Sciences Inc.股票交易,Kodiak Sciences Inc.股票购买,Kodiak Sciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Kodiak Sciences Inc.(KOD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Kodiak Sciences Inc.(KOD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction